Nicholas Robert Hagger Appointed as Independent Director of Biocon

Nicholas Robert Hagger has been appointed an Independent Director of Biocon Limited. The company announced to the stock exchanges.

Nicholas Robert Hagger has rich experience in the pharmaceutical and healthcare sectors. He has held the roles of CEO and Founder of HealthQube Ltd., CEO and Board Member at Zentiva K.S., and advisory positions with Insud, Formycon, Medicines for Europe, and Advent International. In his capacity as CEO at Insud Pharma, he oversaw entities like Chemo, MabXience, and Exeltis. His previous positions include Managing Director at Sandoz International GmbH, Co-chair at Novartis Access to Medicines, and leadership roles at Ranbaxy International and GlaxoSmithKline. He has completed his MBA from Cranfield Institute, a B.Sc. in Industrial and Manufacturing Systems Engineering from the University of Hertfordshire, and executive education from renowned institutions such as Harvard and London Business Schools.